State and problems of clinical trials in Russian Federation

Abstract

The Russian Federation is considered one of the most promising platforms for any phase of clinical trials, the maximum number of which was registered in 2011. The participation in clinical trials is often the only option to get advanced treatment for people, significant budget savings for clinics, and the opportunity to learn to work with new drugs before they enter the practice - for doctors. On average, the number of international clinical trials in our country is 10 times lower than in European countries and the United States, which is associated with a number of problems - legislative, clinical, logistics, diagnostics.

Full Text

##article.viewOnOriginalSite##